4//SEC Filing
Mattes Glenn R. 4
Accession 0001213900-20-037057
CIK 0001733413other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 9:00 PM ET
Size
9.2 KB
Accession
0001213900-20-037057
Insider Transaction Report
Form 4
Mattes Glenn R.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2020-11-10$14.99/sh−108,830$1,631,906→ 10,000 total - Exercise/Conversion
Stock Options (Right to Buy)
2020-11-10−108,830→ 1,104,227 totalExercise: $2.50From: 2019-05-01Exp: 2028-05-01→ Common Stock (108,830 underlying) - Exercise/Conversion
Common Stock
2020-11-10$2.50/sh+108,830$272,075→ 118,830 total
Holdings
- 10,000(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options.
Documents
Issuer
TFF Pharmaceuticals, Inc.
CIK 0001733413
Entity typeother
Related Parties
1- filerCIK 0001568678
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 9:00 PM ET
- Size
- 9.2 KB